Upon stimulation with IFNg, STAT1 activation resulted in PD-L1 upregulation and in reduction of NK-cell activity against tumor cells in multiple myeloma, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL) [57]. The gene discussed is IFNG; the disease is acute myeloid leukemia.